trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
2022 MEDICA Exhibitor’s Recommendation--Guangdong Wesail Biotech Co., Ltd.
2022-11-09
MEDICA is the leading international platform for the medical technology industry. For more than 50 years, it has been a must-attend event in the annual calendar of trade visitors from all areas of the healthcare industry.
Guangdong Wesail Biotech Co., Ltd. will participate in this event at Booth: 17 D46-6 and look forward to meeting you.
Company Profile
Guangdong Wesail Biotech Co., Ltd. will participate in this event at Booth: 17 D46-6 and look forward to meeting you.
Company Profile
Located in Songshan Lake High-Tech Industrial Park, Dongguan, Guangdong Wesail Biotech Co., Ltd. (WESAIL), with its strong business philosophy of “strive for excellence, truth, and reality”, attaches great importance to technological innovation, technological product experiments, and product advancement. The company is committed to supporting IVD customers with exceptional reagents performance and related instruments.
WESAIL is a nationally certified high-tech enterprise, with R&D and marketing teams that have been engaged in the industry for over 20 years. Based on deep insights into the future industry development trends, WESAIL continues to strengthen technology, and build three technology platforms of immunofluorescence, colloidal gold, and chemiluminescence. WESAIL has formed a rich product line, covering cardiovascular diseases, infectious diseases, brain injuries, renal injuries, hormones, metabolic diseases, thyroid diseases, diabetes, birth defects, cancers, and other testing fields, which provides patients with faster, more convenient, more accurate and effective testing services. By accelerating the product layouts in the subdivided fields and promoting industrial technological innovation, we will set sail with customers to the future!
Products Display
Previous Highlights
label :
Medica